NCT01536353View on ClinicalTrials.gov

Clinical Trial to Evaluate the Bioavailability and Safety of AGSAV301

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

August 31, 2012

Conditions
Hypertension
Interventions
DRUG

AGSAV301

tablet, q.d.

DRUG

Exforge 10/160

Tablet, q.d.

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors

Collaborators (1)

Asan Medical Center
All Listed Sponsors
collaborator

Asan Medical Center

OTHER

lead

Ahn-Gook Pharmaceuticals Co.,Ltd

INDUSTRY

NCT01536353 - Clinical Trial to Evaluate the Bioavailability and Safety of AGSAV301 | Biotech Hunter | Biotech Hunter